Home > News > Altair: The Excuses Continue
March 13th, 2006
Altair: The Excuses Continue
Jack Uldrich: I continue to advise my readers to stay away from this company. It issues a lot of meaningless press releases and it is now beginning to issue some far-fetched excuses.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014